Products | Molecular Health

Applications and solutions

Using clinical and molecular data for better decisions

Molecular Health software applications and services allow you to leverage our comprehensive data of clinico-molecular drugs, diseases, and phenotypes for evidence-based drug development, diagnosis, and medication. 

Our applications are designed to predict drug therapy outcomes, clinical trial designs, drug-induced adverse effects, and drug-drug interactions – out-of-the box. Molecular data has finally become meaningful at the clinical level.

Dataome - the world’s biomedical data: integrated, cleaned and curated
The best actions are based on insight. At the center of insight is Dataome. Built and constructed over a decade, our Dataome technology enables the quality-controlled capture, integration, and analysis of clinical and molecular knowledge. By connecting real-world patient outcome data to the real-time state of clinical and molecular knowledge, Dataome provides an unparalleled evidence base upon which decision support solutions for the healthcare industry are built.
Read more
Dataome - the world’s biomedical data: integrated, cleaned and curated
Read more

Gaining insights has never been easier

Dataome has become one of the largest globally available resources of clinico-molecular data and knowledge. From millions of patient lives to hundreds of billions of molecular data points, it provides a single point of access to the world’s biomedical knowledge through our decision support applications.

 

Molecular Health Guide (MH Guide) identifies safe and effective medication for cancer patients by analyzing the cancer’s molecular profile. It matches detected tumor mutations to the world’s knowledge in the field of oncology and helps medical experts to create a patient-specific clinical report with treatment recommendations.

 

 

Molecular Health Guide Mendel (MH Mendel) supports human geneticists in diagnosing hereditary diseases and creating diagnostic reports for individuals. The germline data analysis follows official genetic guidelines and uses the latest, world known ACMG variant classification criteria.

 

Logo of MH BRCA

 

Molecular Health Guide BRCA (MH BRCA) supports medical professionals in identifying and reporting clinically significant germline variants for hereditary breast and ovarian cancer.  It creates individual patient reports based on NGS data from BRCA1/BRCA2 and other associated genes following official genetic guidelines. 

 

MH Predict Logo


Molecular Health Predict (MH Predict) is an application to predict clinical trials probabilities of success. It enables the improvement of clinical trial success and reduces clinical trial failure while optimizing resource allocation for the biopharma industry and investors and enhancing the overall efficiency of drug development.

 

Let’s talk about how our products can work for you.

Call us for a product demo.

Phone: +1 346-221-1955

E-mail: CustomerCareUS@molecularhealth.com